[link removed]
🚨 BREAKING NEWS FROM SCOTUS 🚨
Dear Team,
The U.S. Supreme Court just ruled that people can keep getting mifepristone by mail and at their local pharmacy—for now. [[link removed]]
This is not a victory. It's a pause. The anti-abortion movement is not slowing down. And neither are we. [[link removed]]
DEFEND ABORTION CARE [[link removed]]
Here's what happened: Earlier this month, the Fifth Circuit sided with Louisiana and reinstated a medically unnecessary requirement that mifepristone be dispensed in person, threatening access by mail and at pharmacies nationwide. The Supreme Court paused that order. Today, it extended that pause while the case continues.
This back-and-forth has already caused real chaos for providers and patients. It won't stop here. [[link removed]]
Medication abortion accounts for more than 60% of abortions in the U.S. each year. More than 7.5 million people have used mifepristone safely. Hundreds of studies back it. Restricting it is not about safety—it's about making abortion as difficult, expensive, and unreachable as possible. [[link removed]]
The people hit hardest: those with low incomes. People in rural areas, hours from the nearest clinic. People with disabilities. People escaping domestic violence.
PROTECT MIFE [[link removed]]
The Center for Reproductive Rights has been in this fight at every moment — in close contact with providers, preparing for what comes next.
But stopping these attacks requires sustained legal action, and our ability to fight and win depends on people like you. [[link removed]] Today is a moment to breathe. Tomorrow, we keep fighting. [[link removed]]
In solidarity,
Center for Reproductive Rights
DONATE NOW [[link removed]]
[link removed]
[link removed]
[link removed]
[link removed]
reproductiverights.org
The Center for Reproductive Rights uses the power of law to advance reproductive rights as fundamental human rights around the world.
© Center for Reproductive Rights
Center for Reproductive Rights
199 Water St.
New York, NY 10038
United States unsubscribe: [link removed]